BRAFV600E Mutations in Thyroid Carcinomas: Is There a Role for BRAF Immunohistochemistry?

被引：0
|
作者：
Fisher, K. E. [1 ]
Ehsani, L. [1 ]
Neill, S. G. [1 ]
Caltharp, S. A. [1 ]
Siddiqui, M. T. [1 ]
Cohen, C. [1 ]
机构：
[1] Emory Univ, Sch Med, Atlanta, GA USA
来源：
MODERN PATHOLOGY | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
547
引用
收藏
页码：132A / 132A
页数：1
相关论文
共 50 条
  • [21] The Relationship of the BRAFV600E Mutation and the Established Prognostic Factors in Papillary Thyroid Carcinomas
    Bülent Kurt
    Serap Yalçın
    Engin Alagöz
    Yıldırım Karslıoğlu
    Nuri Yigit
    Armağan Günal
    M. Salih Deveci
    [J]. Endocrine Pathology, 2012, 23 : 135 - 140
  • [22] BRAFV600E mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas
    Durante, Cosimo
    Tallini, Giovanni
    Puxeddu, Efisio
    Sponziello, Marialuisa
    Moretti, Sonia
    Ligorio, Claudia
    Cavaliere, Antonio
    Rhoden, Kerry J.
    Verrienti, Antonella
    Maranghi, Marianna
    Giacomelli, Laura
    Russo, Diego
    Filetti, Sebastiano
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 165 (03) : 455 - 463
  • [23] The Relationship of the BRAFV600E Mutation and the Established Prognostic Factors in Papillary Thyroid Carcinomas
    Kurt, Bulent
    Yalcin, Serap
    Alagoz, Engin
    Karslioglu, Yildirim
    Yigit, Nuri
    Gunal, Armagan
    Deveci, M. Salih
    [J]. ENDOCRINE PATHOLOGY, 2012, 23 (03) : 135 - 140
  • [24] BRAFV600E Mutation Does Not Mean Distant Metastasis in Thyroid Papillary Carcinomas
    Sancisi, Valentina
    Nicoli, Davide
    Ragazzi, Moira
    Piana, Simonetta
    Ciarrocchi, Alessia
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (09): : E1745 - E1749
  • [25] Prognostic Significance of TERT Promoter Mutations in Papillary Thyroid Carcinomas in a BRAFV600E Mutation-Prevalent Population
    Lee, Seung Eun
    Hwang, Tae Sook
    Choi, Yoon-La
    Han, Hye Seung
    Kim, Wan Seop
    Jang, Min Hye
    Kim, Suk Kyeong
    Yang, Jung Hyun
    [J]. THYROID, 2016, 26 (07) : 901 - 910
  • [26] Frequent BRAFV600E and Absence of TERT Promoter Mutations Characterize Sporadic Pediatric Papillary Thyroid Carcinomas in Japan
    Naoki Oishi
    Tetsuo Kondo
    Tadao Nakazawa
    Kunio Mochizuki
    Tomohiro Inoue
    Kazunari Kasai
    Ippei Tahara
    Tomonori Yabuta
    Mitsuyoshi Hirokawa
    Akira Miyauchi
    Ryohei Katoh
    [J]. Endocrine Pathology, 2017, 28 : 103 - 111
  • [27] BRAF Immunohistochemistry Using Clone VE1 is Strongly Concordant with BRAFV600E Mutation Test in Papillary Thyroid Carcinoma
    Jung-Soo Pyo
    Jin Hee Sohn
    Guhyun Kang
    [J]. Endocrine Pathology, 2015, 26 : 211 - 217
  • [28] BRAFV600E mutations in serous ovarian cancer and response to the BRAF inhibitor, dabrafenib.
    DeFazio, Anna
    Moujaber, Tania
    Etemadmoghadam, Dariush
    Kennedy, Catherine
    Chiew, Yoke-Eng
    Balleine, Rosemary L.
    Saunders, Catherine
    Wain, Gerard V.
    Dobrovic, Alexander
    Bowtell, David D. L.
    Harnett, Paul R.
    [J]. CLINICAL CANCER RESEARCH, 2016, 22
  • [29] BRAF Immunohistochemistry Using Clone VE1 is Strongly Concordant with BRAFV600E Mutation Test in Papillary Thyroid Carcinoma
    Pyo, Jung-Soo
    Sohn, Jin Hee
    Kang, Guhyun
    [J]. ENDOCRINE PATHOLOGY, 2015, 26 (03) : 211 - 217
  • [30] Comparison of Immunohistochemistry and Direct Sanger Sequencing for Detection of the BRAFV600E Mutation in Thyroid Neoplasm
    Oh, Hye-Seon
    Kwon, Hyemi
    Park, Suyeon
    Kim, Mijin
    Jeon, Min Ji
    Kim, Tae Yong
    Shong, Young Kee
    Kim, Won Bae
    Choi, Jene
    Kim, Won Gu
    Song, Dong Eun
    [J]. ENDOCRINOLOGY AND METABOLISM, 2018, 33 (01) : 62 - 69
12345